{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:16:59Z","timestamp":1791919019182,"version":"4.3.4"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,5,5]],"date-time":"2021-05-05T00:00:00Z","timestamp":1620172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,5,5]],"date-time":"2021-05-05T00:00:00Z","timestamp":1620172800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Osteoporosis and other manifestations of bone disease are frequent in patients with systemic mastocytosis (SM) in association with the presence of mast cell infiltrates in bone marrow, although the mechanisms behind bone disease remain poorly understood. We find that extracellular vesicles (EVs) released by neoplastic mast cells and present in the serum of patients with SM (SM-EVs) block osteoblast differentiation and mineralization in culture, and when injected into mice diminish the expression of osteoblast markers, and trabecular bone volume and microarchitecture. We demonstrate that miRNA-30a and miRNA-23a, increased in SM-EVs and neoplastic mast cell-derived EVs, attenuate osteoblast maturation by suppressing expression of RUNX2 and SMAD1\/5, essential drivers of osteogenesis. Thus, SM-EVs carry and deliver miRNAs that epigenetically interfere with bone formation and can contribute to bone mass reduction in SM. These findings also suggest possibilities for novel approaches to the management of bone disease in mast cell proliferative disorders.<\/jats:p>","DOI":"10.1038\/s41467-021-22754-4","type":"journal-article","created":{"date-parts":[[2021,5,5]],"date-time":"2021-05-05T06:04:15Z","timestamp":1620194655000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":75,"title":["Mastocytosis-derived extracellular vesicles deliver miR-23a and miR-30a into pre-osteoblasts and prevent osteoblastogenesis and bone formation"],"prefix":"10.1038","volume":"12","author":[{"given":"Do-Kyun","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geethani","family":"Bandara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young-Eun","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirsh D.","family":"Komarow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3371-665X","authenticated-orcid":false,"given":"Danielle R.","family":"Donahue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baktiar","family":"Karim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4266-1048","authenticated-orcid":false,"given":"Moon-Chang","family":"Baek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0029-3643","authenticated-orcid":false,"given":"Ho Min","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7781-8260","authenticated-orcid":false,"given":"Dean D.","family":"Metcalfe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0128-5461","authenticated-orcid":false,"given":"Ana","family":"Olivera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,5,5]]},"reference":[{"key":"22754_CR1","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.iac.2014.01.002","volume":"34","author":"G Cruse","year":"2014","unstructured":"Cruse, G., Metcalfe, D. D. & Olivera, A. Functional deregulation of KIT: link to mast cell proliferative diseases and other neoplasms. Immunol. Allergy Clin. North Am. 34, 219\u2013237 (2014).","journal-title":"Immunol. Allergy Clin. North Am."},{"key":"22754_CR2","doi-asserted-by":"publisher","first-page":"75.e1","DOI":"10.1016\/j.amjmed.2012.07.018","volume":"126","author":"N Guillaume","year":"2013","unstructured":"Guillaume, N. et al. Bone complications of mastocytosis: a link between clinical and biological characteristics. Am. J. Med. 126, 75.e1\u201375.e7 (2013).","journal-title":"Am. J. Med."},{"key":"22754_CR3","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.iac.2018.04.013","volume":"38","author":"G Orsolini","year":"2018","unstructured":"Orsolini, G., Viapiana, O., Rossini, M., Bonifacio, M. & Zanotti, R. Bone disease in mastocytosis. Immunol. Allergy Clin. N. Am. 38, 443\u2013454 (2018).","journal-title":"Immunol. Allergy Clin. N. Am."},{"key":"22754_CR4","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.iac.2014.01.011","volume":"34","author":"M Rossini","year":"2014","unstructured":"Rossini, M. et al. Bone involvement and osteoporosis in mastocytosis. Immunol. Allergy Clin. N. Am. 34, 383\u2013396 (2014).","journal-title":"Immunol. Allergy Clin. N. Am."},{"key":"22754_CR5","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/S0145-2126(02)00168-6","volume":"27","author":"P Valent","year":"2003","unstructured":"Valent, P. et al. Aggressive systemic mastocytosis and related mast cell disorders: current treatment options and proposed response criteria. Leuk. Res. 27, 635\u2013641 (2003).","journal-title":"Leuk. Res."},{"key":"22754_CR6","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1016\/j.jaci.2013.06.019","volume":"132","author":"A Rabenhorst","year":"2013","unstructured":"Rabenhorst, A. et al. Serum levels of bone cytokines are increased in indolent systemic mastocytosis associated with osteopenia or osteoporosis. J. Allergy Clin. Immunol. 132, 1234\u20131237.e7 (2013).","journal-title":"J. Allergy Clin. Immunol."},{"key":"22754_CR7","doi-asserted-by":"publisher","first-page":"2325","DOI":"10.1007\/s00198-013-2305-x","volume":"24","author":"S Seitz","year":"2013","unstructured":"Seitz, S. et al. Increased osteoblast and osteoclast indices in individuals with systemic mastocytosis. Osteoporos. Int. 24, 2325\u20132334 (2013).","journal-title":"Osteoporos. Int."},{"key":"22754_CR8","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1159\/000063858","volume":"128","author":"TC Theoharides","year":"2002","unstructured":"Theoharides, T. C., Boucher, W. & Spear, K. Serum interleukin-6 reflects disease severity and osteoporosis in mastocytosis patients. Int. Arch. Allergy Immunol. 128, 344\u2013350 (2002).","journal-title":"Int. Arch. Allergy Immunol."},{"key":"22754_CR9","first-page":"11","volume":"5","author":"L Masi","year":"2008","unstructured":"Masi, L. Epidemiology of osteoporosis. Clin. Cases Min. Bone Metab. 5, 11\u201313 (2008).","journal-title":"Clin. Cases Min. Bone Metab."},{"key":"22754_CR10","first-page":"204","volume":"8","author":"MP Yavropoulou","year":"2008","unstructured":"Yavropoulou, M. P. & Yovos, J. G. Osteoclastogenesis\u2014current knowledge and future perspectives. J. Musculoskelet. Neuronal Interact. 8, 204\u2013216 (2008).","journal-title":"J. Musculoskelet. Neuronal Interact."},{"key":"22754_CR11","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1159\/000205430","volume":"19","author":"T Gillman","year":"1958","unstructured":"Gillman, T. Mast cell increases after calciferol intoxication and in experimental odoratism. Acta Haematol. 19, 179\u2013186 (1958).","journal-title":"Acta Haematol."},{"key":"22754_CR12","first-page":"239","volume":"63","author":"MR Urist","year":"1957","unstructured":"Urist, M. R. & McLean, F. C. Accumulation of mast cells in endosteum of bones of calcium-deficient rats. AMA Arch. Pathol. 63, 239\u2013251 (1957).","journal-title":"AMA Arch. Pathol."},{"key":"22754_CR13","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/S8756-3282(02)00875-X","volume":"31","author":"C Brumsen","year":"2002","unstructured":"Brumsen, C., Papapoulos, S. E., Lentjes, E. G., Kluin, P. M. & Hamdy, N. A. A potential role for the mast cell in the pathogenesis of idiopathic osteoporosis in men. Bone 31, 556\u2013561 (2002).","journal-title":"Bone"},{"key":"22754_CR14","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1056\/NEJM196809192791203","volume":"279","author":"B Frame","year":"1968","unstructured":"Frame, B. & Nixon, R. K. Bone-marrow mast cells in osteoporosis of aging. N. Engl. J. Med. 279, 626\u2013630 (1968).","journal-title":"N. Engl. J. Med."},{"key":"22754_CR15","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.semarthrit.2006.03.004","volume":"36","author":"N Chiappetta","year":"2006","unstructured":"Chiappetta, N. & Gruber, B. The role of mast cells in osteoporosis. Semin Arthritis Rheum. 36, 32\u201336 (2006).","journal-title":"Semin Arthritis Rheum."},{"key":"22754_CR16","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1369\/0022155417734174","volume":"65","author":"WMA Maximiano","year":"2017","unstructured":"Maximiano, W. M. A. et al. Mast cell mediators inhibit osteoblastic differentiation and extracellular matrix mineralization. J. Histochem. Cytochem. 65, 723\u2013741 (2017).","journal-title":"J. Histochem. Cytochem."},{"key":"22754_CR17","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1002\/jbmr.3332","volume":"33","author":"A Cappariello","year":"2018","unstructured":"Cappariello, A. et al. Osteoblast-derived extracellular vesicles are biological tools for the delivery of active molecules to bone. J. Bone Min. Res. 33, 517\u2013533 (2018).","journal-title":"J. Bone Min. Res."},{"key":"22754_CR18","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1038\/s41413-018-0039-2","volume":"6","author":"M Gao","year":"2018","unstructured":"Gao, M. et al. Exosomes\u2014the enigmatic regulators of bone homeostasis. Bone Res. 6, 36 (2018).","journal-title":"Bone Res."},{"key":"22754_CR19","doi-asserted-by":"publisher","first-page":"181","DOI":"10.18632\/oncoscience.421","volume":"5","author":"J Behera","year":"2018","unstructured":"Behera, J. & Tyagi, N. Exosomes: mediators of bone diseases, protection, and therapeutics potential. Oncoscience 5, 181\u2013195 (2018).","journal-title":"Oncoscience"},{"key":"22754_CR20","doi-asserted-by":"publisher","first-page":"628","DOI":"10.3389\/fphys.2018.00628","volume":"9","author":"FL Yuan","year":"2018","unstructured":"Yuan, F. L. et al. Osteoclast-derived extracellular vesicles: novel regulators of osteoclastogenesis and osteoclast-osteoblasts communication in bone remodeling. Front Physiol. 9, 628 (2018).","journal-title":"Front Physiol."},{"key":"22754_CR21","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.ceb.2015.04.013","volume":"35","author":"A Lo Cicero","year":"2015","unstructured":"Lo Cicero, A., Stahl, P. D. & Raposo, G. Extracellular vesicles shuffling intercellular messages: for good or for bad. Curr. Opin. Cell Biol. 35, 69\u201377 (2015).","journal-title":"Curr. Opin. Cell Biol."},{"key":"22754_CR22","doi-asserted-by":"publisher","first-page":"E10692","DOI":"10.1073\/pnas.1809938115","volume":"115","author":"DK Kim","year":"2018","unstructured":"Kim, D. K. et al. Mastocytosis-derived extracellular vesicles exhibit a mast cell signature, transfer KIT to stellate cells, and promote their activation. Proc. Natl Acad. Sci. U. S. A. 115, E10692\u2013E10701 (2018).","journal-title":"Proc. Natl Acad. Sci. U. S. A."},{"key":"22754_CR23","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1002\/jbmr.5650100203","volume":"10","author":"SA Harris","year":"1995","unstructured":"Harris, S. A., Enger, R. J., Riggs, B. L. & Spelsberg, T. C. Development and characterization of a conditionally immortalized human fetal osteoblastic cell line. J. Bone Min. Res. 10, 178\u2013186 (1995).","journal-title":"J. Bone Min. Res."},{"key":"22754_CR24","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1002\/jcb.10259","volume":"87","author":"M Subramaniam","year":"2002","unstructured":"Subramaniam, M. et al. Further characterization of human fetal osteoblastic hFOB 1.19 and hFOB\/ER alpha cells: bone formation in vivo and karyotype analysis using multicolor fluorescent in situ hybridization. J. Cell Biochem. 87, 9\u201315 (2002).","journal-title":"J. Cell Biochem."},{"key":"22754_CR25","doi-asserted-by":"publisher","first-page":"16009","DOI":"10.1038\/boneres.2016.9","volume":"4","author":"M Wu","year":"2016","unstructured":"Wu, M., Chen, G. & Li, Y. P. TGF-beta and BMP signaling in osteoblast, skeletal development, and bone formation, homeostasis and disease. Bone Res. 4, 16009 (2016).","journal-title":"Bone Res."},{"key":"22754_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms2313","volume":"3","author":"JM Kim","year":"2012","unstructured":"Kim, J. M. et al. DJ-1 promotes angiogenesis and osteogenesis by activating FGF receptor-1 signaling. Nat. Commun. 3, 1296 (2012).","journal-title":"Nat. Commun."},{"key":"22754_CR27","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.cell.2019.02.029","volume":"177","author":"DK Jeppesen","year":"2019","unstructured":"Jeppesen, D. K. et al. Reassessment of exosome composition. Cell 177, 428\u2013445.e18 (2019).","journal-title":"Cell"},{"key":"22754_CR28","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1038\/nrendo.2011.234","volume":"8","author":"JB Lian","year":"2012","unstructured":"Lian, J. B. et al. MicroRNA control of bone formation and homeostasis. Nat. Rev. Endocrinol. 8, 212\u2013227 (2012).","journal-title":"Nat. Rev. Endocrinol."},{"key":"22754_CR29","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1038\/bonekey.2014.44","volume":"3","author":"B Ell","year":"2014","unstructured":"Ell, B. & Kang, Y. MicroRNAs as regulators of bone homeostasis and bone metastasis. Bonekey Rep. 3, 549 (2014).","journal-title":"Bonekey Rep."},{"key":"22754_CR30","doi-asserted-by":"crossref","unstructured":"Sun M. et al. The regulatory roles of MicroRNAs in bone remodeling and perspectives as biomarkers in osteoporosis. Biomed. Res. Int. 2016, 1652417 (2016).","DOI":"10.1155\/2016\/1652417"},{"key":"22754_CR31","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1002\/jbmr.2175","volume":"29","author":"C Seeliger","year":"2014","unstructured":"Seeliger, C. et al. Five freely circulating miRNAs and bone tissue miRNAs are associated with osteoporotic fractures. J. Bone Min. Res. 29, 1718\u20131728 (2014).","journal-title":"J. Bone Min. Res."},{"key":"22754_CR32","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1002\/jbmr.1621","volume":"27","author":"L Yang","year":"2012","unstructured":"Yang, L. et al. miR-93\/Sp7 function loop mediates osteoblast mineralization. J. Bone Min. Res. 27, 1598\u20131606 (2012).","journal-title":"J. Bone Min. Res."},{"key":"22754_CR33","doi-asserted-by":"publisher","first-page":"19879","DOI":"10.1073\/pnas.1007698107","volume":"107","author":"MQ Hassan","year":"2010","unstructured":"Hassan, M. Q. et al. A network connecting Runx2, SATB2, and the miR-23a~27a~24-2 cluster regulates the osteoblast differentiation program. Proc. Natl Acad. Sci. U. S. A. 107, 19879\u201319884 (2010).","journal-title":"Proc. Natl Acad. Sci. U. S. A."},{"key":"22754_CR34","doi-asserted-by":"publisher","first-page":"7503","DOI":"10.1074\/jbc.M111.292722","volume":"287","author":"T Wu","year":"2012","unstructured":"Wu, T. et al. miR-30 family members negatively regulate osteoblast differentiation. J. Biol. Chem. 287, 7503\u20137511 (2012).","journal-title":"J. Biol. Chem."},{"key":"22754_CR35","doi-asserted-by":"publisher","first-page":"3479","DOI":"10.1007\/s13277-015-4086-7","volume":"37","author":"R Zhang","year":"2016","unstructured":"Zhang, R. et al. MiR-30a regulates the proliferation, migration, and invasion of human osteosarcoma by targeting Runx2. Tumour Biol. 37, 3479\u20133488 (2016).","journal-title":"Tumour Biol."},{"key":"22754_CR36","doi-asserted-by":"publisher","first-page":"e42390","DOI":"10.1371\/journal.pone.0042390","volume":"7","author":"TP Lu","year":"2012","unstructured":"Lu, T. P. et al. miRSystem: an integrated system for characterizing enriched functions and pathways of microRNA targets. PloS ONE 7, e42390 (2012).","journal-title":"PloS ONE"},{"key":"22754_CR37","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/j.jaci.2009.05.003","volume":"124","author":"L Escribano","year":"2009","unstructured":"Escribano, L. et al. Prognosis in adult indolent systemic mastocytosis: a long-term study of the Spanish Network on Mastocytosis in a series of 145 patients. J. Allergy Clin. Immunol. 124, 514\u2013521 (2009).","journal-title":"J. Allergy Clin. Immunol."},{"key":"22754_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-018-0139-7","volume":"8","author":"S Faict","year":"2018","unstructured":"Faict, S. et al. Exosomes play a role in multiple myeloma bone disease and tumor development by targeting osteoclasts and osteoblasts. Blood Cancer J. 8, 105 (2018).","journal-title":"Blood Cancer J."},{"key":"22754_CR39","doi-asserted-by":"publisher","first-page":"20","DOI":"10.2174\/2211536611302010004","volume":"2","author":"BT Moore","year":"2013","unstructured":"Moore, B. T. & Xiao, P. MiRNAs in bone diseases. Microrna 2, 20\u201331 (2013).","journal-title":"Microrna"},{"key":"22754_CR40","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.mce.2015.10.015","volume":"432","author":"M Hackl","year":"2016","unstructured":"Hackl, M., Heilmeier, U., Weilner, S. & Grillari, J. Circulating microRNAs as novel biomarkers for bone diseases\u2014complex signatures for multifactorial diseases? Mol. Cell Endocrinol. 432, 83\u201395 (2016).","journal-title":"Mol. Cell Endocrinol."},{"key":"22754_CR41","doi-asserted-by":"publisher","first-page":"3068","DOI":"10.2741\/2296","volume":"12","author":"W Huang","year":"2007","unstructured":"Huang, W., Yang, S., Shao, J. & Li, Y. P. Signaling and transcriptional regulation in osteoblast commitment and differentiation. Front Biosci. 12, 3068\u20133092 (2007).","journal-title":"Front Biosci."},{"key":"22754_CR42","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1359\/jbmr.060109","volume":"21","author":"M Phimphilai","year":"2006","unstructured":"Phimphilai, M., Zhao, Z., Boules, H., Roca, H. & Franceschi, R. T. BMP signaling is required for RUNX2-dependent induction of the osteoblast phenotype. J. Bone Min. Res. 21, 637\u2013646 (2006).","journal-title":"J. Bone Min. Res."},{"key":"22754_CR43","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1016\/j.bone.2011.07.004","volume":"49","author":"M Rossini","year":"2011","unstructured":"Rossini, M. et al. Bone mineral density, bone turnover markers and fractures in patients with indolent systemic mastocytosis. Bone 49, 880\u2013885 (2011).","journal-title":"Bone"},{"key":"22754_CR44","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/aps.2017.162","volume":"39","author":"S Samanta","year":"2018","unstructured":"Samanta, S. et al. Exosomes: new molecular targets of diseases. Acta Pharm. Sin. 39, 501\u2013513 (2018).","journal-title":"Acta Pharm. Sin."},{"key":"22754_CR45","doi-asserted-by":"publisher","first-page":"L110","DOI":"10.1152\/ajplung.00423.2016","volume":"312","author":"D Zhang","year":"2017","unstructured":"Zhang, D., Lee, H., Zhu, Z., Minhas, J. K. & Jin, Y. Enrichment of selective miRNAs in exosomes and delivery of exosomal miRNAs in vitro and in vivo. Am. J. Physiol. Lung Cell Mol. Physiol. 312, L110\u2013L121 (2017).","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"22754_CR46","unstructured":"Horny H. P. et al. Mastocytosis. In: WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues 2008 edn, (eds Swerdlow, S. H. et al.) (IARC Press, 2008)."},{"key":"22754_CR47","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1146\/annurev-pathol-052016-100312","volume":"12","author":"DD Metcalfe","year":"2017","unstructured":"Metcalfe, D. D. & Mekori, Y. A. Pathogenesis and pathology of mastocytosis. Annu Rev. Pathol. 12, 487\u2013514 (2017).","journal-title":"Annu Rev. Pathol."},{"key":"22754_CR48","doi-asserted-by":"publisher","first-page":"2429","DOI":"10.1182\/blood-2016-09-742296","volume":"129","author":"S Manier","year":"2017","unstructured":"Manier, S. et al. Prognostic role of circulating exosomal miRNAs in multiple myeloma. Blood 129, 2429\u20132436 (2017).","journal-title":"Blood"},{"key":"22754_CR49","doi-asserted-by":"publisher","first-page":"3202","DOI":"10.1182\/blood-2014-11-611046","volume":"125","author":"MS Njock","year":"2015","unstructured":"Njock, M. S. et al. Endothelial cells suppress monocyte activation through secretion of extracellular vesicles containing antiinflammatory microRNAs. Blood 125, 3202\u20133212 (2015).","journal-title":"Blood"},{"key":"22754_CR50","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1046\/j.1365-2567.2003.01559.x","volume":"108","author":"M Sundstrom","year":"2003","unstructured":"Sundstrom, M. et al. Functional and phenotypic studies of two variants of a human mast cell line with a distinct set of mutations in the c-kit proto-oncogene. Immunology 108, 89\u201397 (2003).","journal-title":"Immunology"},{"key":"22754_CR51","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/0145-2126(88)90050-1","volume":"12","author":"JH Butterfield","year":"1988","unstructured":"Butterfield, J. H., Weiler, D., Dewald, G. & Gleich, G. J. Establishment of an immature mast cell line from a patient with mast cell leukemia. Leuk. Res. 12, 345\u2013355 (1988).","journal-title":"Leuk. Res."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-22754-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-22754-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-22754-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,2]],"date-time":"2022-12-02T06:55:45Z","timestamp":1669964145000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-22754-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,5]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["22754"],"URL":"https:\/\/doi.org\/10.1038\/s41467-021-22754-4","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.740069813.793597274","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,5]]},"assertion":[{"value":"23 May 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2527"}}